<DOC>
	<DOCNO>NCT01438723</DOCNO>
	<brief_summary>Rationale : In patient myocardial infarction , occlusion coronary artery induces myocardial ischemia cell death . If untreated , area myocardium expose interruption blood supply , largely become necrotic . The way limit final infarct size , timely reperfusion occlude artery . Paradoxically , however , reperfusion also damage myocardial tissue contribute final infarct size ( `` reperfusion injury '' ) . Also coronary artery bypass grafting ( CABG ) , myocardium expose ischemia reperfusion , induce cell death . Indeed , postoperatively , plasma concentration troponin I , marker cardiac necrosis , increase , associated adverse outcome . The anti-hyperglycaemic drug metformin show preclinical study able reduce ischemia-reperfusion injury limit myocardial infarct size . Moreover , metformin therapy improve cardiovascular prognosis patient diabetes mellitus . Paradoxically , patient diabetes , current practice temporarily stop metformin major surgery presume risk lactic acidosis , rare complication metformin . However , evidence practice benefit patient . The investigator hypothesize pretreatment metformin reduce myocardial injury patient undergo elective CABG surgery</brief_summary>
	<brief_title>The Metformin Coronary Artery Bypass Graft ( CABG ) ( MetCAB ) Trial</brief_title>
	<detailed_description />
	<mesh_term>Cardiovascular Diseases</mesh_term>
	<mesh_term>Heart Diseases</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Metformin</mesh_term>
	<criteria>Acceptation CABG without concomitant valve surgery Informed consent Age â‰¥ 18 year Diabetes mellitus Renal dysfunction ( MDRD &lt; 60 ml/min ) Elevated liver enzyme ( ALAT &gt; 3 time upper limit reference range ) Treatment dipyridamole xanthine derivative Recent myocardial infarction ( &lt; 2 week inclusion ) Offpump surgery</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2011</verification_date>
	<keyword>ischemia reperfusion injury</keyword>
	<keyword>CABG</keyword>
	<keyword>metformin</keyword>
	<keyword>Hs-troponin-I</keyword>
</DOC>